Tyler Shultz and Erika Cheung are the whistleblowers who exposed Elizabeth Holmes' illegal, often life-threatening practices at Theranos. The Wall Street Journal broke the story in 2015 that the company's technology didn't work, and it has tracked the scandal ever since - through Holmes' indictment, trial, and the long legal tail that is still running in 2026.
Theranos - Silicon Valley's darling
Theranos was founded in 2003 by a 19-year-old Stanford dropout, Elizabeth Holmes. The pitch: stop forcing patients through slow, expensive lab workflows and replace them with a single small device that could do hundreds of tests from a fingerstick sample.
Elizabeth Holmes - TechCrunch Disrupt, September 8, 2014, San Francisco / ©TechCrunch (CC BY 2.0)
Holmes said her machine could detect hundreds of diseases from a few drops of blood pricked from a patient's finger. Lab queues would shrink, cancer patients would get faster and less painful tests, and eventually every household could own one of the machines and screen themselves at home.
The device - Edison - never worked. Only 12 of 100 patient samples came back with correct results. Theranos' scientists could not make the underlying technology do what the marketing claimed.
Holmes did not back off. Nicknamed in the press "the next Steve Jobs", she convinced senior figures in business and politics to keep backing her, eventually raising close to a billion dollars.
She lied repeatedly to do it. Investors were shown fabricated Edison results, while real patient samples were quietly run on competitors' commercial analysers - and Theranos would then claim its own device had produced the numbers.
Theranos whistleblowers
Two junior lab employees changed the trajectory of the company: Erika Cheung and Tyler Shultz, the latter a grandson of one of Theranos' main investors, former US Secretary of State George Shultz. Both were hired straight out of college.
Erika Cheung / TEDx
Running routine blood tests, they quickly noticed the gap between what Theranos told the outside world and what was actually happening on the lab bench. The unusually strict internal secrecy started to make sense once they understood how little of the Edison story was real.
Theranos was lying to both investors and patients. Employees were being told to run clinical samples on Siemens analysers - a competitor's commercial hardware - and report the results as if Edison had produced them. Staff were bound by aggressive non-disclosure agreements that threatened multi-million-dollar penalties for speaking up.
"To me it seemed kind of as a final resort to get the truth out about what was happening with these patient samples"
Cheung @ The Wall Street Journal
Plenty of people inside the company were uneasy; Cheung and Shultz were the ones who acted. In 2015 they took what they knew to John Carreyrou at The Wall Street Journal. Carreyrou's article was the turning point for Holmes' career and her company.
Tyler Shultz / Audible
The revelations drew in the media and US regulators. Theranos' lawyers tried to intimidate the WSJ and the whistleblowers into silence - it didn't stop the story.
"It was clear that there was an open secret within Theranos that this technology simply didn't exist"
Shultz @ National Public Radio (NPR)
In April 2016, federal prosecutors and the U.S. Securities and Exchange Commission (SEC) opened investigations into Holmes and her COO and then-partner Ramesh "Sunny" Balwani for misleading investors and regulators about Theranos' technology. Criminal charges followed.
Elizabeth A. Holmes and Ramesh "Sunny" Balwani (...), are charged with wire fraud, in violation of 18 U.S.C. §1343, and conspiracy to commit wire fraud, in violation of 18 U.S.C. §1349. The charges stem from Defendants' allegedly deceptive representations about their company and its medical testing technology.
United States v. Elizabeth A. Holmes, et al. 18-CR-00258-EJD
Elizabeth Holmes trial
Theranos shut down after 15 years of operation. Holmes went from paper billionaire - once on the Forbes list at a peak $4.5B - to bankrupt. In late 2022, Holmes was sentenced to 11 years and 3 months in federal prison for defrauding investors; Balwani received about 13 years in a separate trial.
"I am happy that she was found guilty of these crimes and I feel like I got my vindication from that, and I feel good about that."
Shultz @ CBS News
Balwani reported to federal prison in April 2023. Holmes married Billy Evans - heir to the Evans Hotel Group - in a private ceremony in 2019, and the couple had two children (July 2021 and February 2023). After exhausting her last bail appeal, she reported to the Federal Prison Camp in Bryan, Texas on 30 May 2023. A separate May 2023 ruling ordered Holmes and Balwani to pay $452 million in restitution to defrauded investors.
Cheung and Shultz are widely cited as modern whistleblowers whose work had a concrete effect: Theranos' practices were stopped, and patients stopped being exposed to unreliable tests.
Inside FPC Bryan
FPC Bryan is a minimum-security federal prison camp for women - dormitory housing, a small staff, no barbed wire. Inmates are assigned to jobs in food service or the on-site factory at wages of $0.12 to $1.15 per hour, wear khaki uniforms, and may see family during weekend and federal-holiday visiting hours. Personal jewellery is banned apart from a wedding band or a simple religious medallion worth no more than $100.
What's happened since 2023
The Theranos story has continued to move, even with Holmes locked up in Texas.
Sentence reductions. In July 2023, good-conduct time credits shaved roughly two years off Holmes' sentence, shifting her projected release to the end of 2032. Further reductions since have pulled the Bureau of Prisons' projected release date forward - by early 2026, public-record release dates put her out around December 2031, about six years earlier than the original sentence.
Appeals exhausted. In June 2024 the Ninth Circuit Court of Appeals heard oral arguments on Holmes' conviction and sentence. In February 2025 the panel rejected her arguments and upheld both the conviction and the sentence. A separate appeal of the $452M restitution order remains pending.
A pardon campaign. In December 2025 the Los Angeles Times reported that Holmes had begun lobbying for a presidential pardon from Donald Trump. In January 2026 the DOJ's Office of the Pardon Attorney confirmed a formal commutation request is on file - with nearly six years of the sentence still to serve.
A Twitter comeback (of sorts). In September 2025, an X account in Holmes' name reactivated and has posted thousands of times - on free-speech themes, prison-life complaints, and advice to her younger self. The bio reads "Mostly my words, posted by others." The Bureau of Prisons says inmates at FPC Bryan cannot access the internet or social media, so the account is being run by proxies; reporting suggests three or four people operate it, with Holmes coordinating through monitored phone calls and mail.
One of the account's most-viewed posts landed on February 16, 2026 - an edited "throwback" photo dropping Holmes into a Theranos lab alongside Tupac, Biggie, Eminem and Snoop Dogg. It drew roughly 5 million views, and the thread's follow-up cut harder: "Today I learned I have more time in prison than the 4 of them combined." However the pardon request resolves, the account has already made clear that Holmes' public persona is being actively managed from behind the fence.
Throwback to the weirdest demo I gave at Theranos.
- Elizabeth Holmes (@ElizabethHolmes) February 16, 2026
Haemanthus. In May 2025, Holmes' partner Billy Evans went public with Haemanthus, a diagnostics startup he had quietly incorporated in February 2024. The company says it is building AI-assisted optical devices (using Raman spectroscopy) to test blood, urine, and saliva - first for pets, then for humans, with an eventual wearable product. Evans has raised roughly $18.5 million. The stated company line is "this is not Theranos 2.0"; Holmes has no formal role but is reportedly advising Evans from prison, which, given her ban on serving as an officer or director of a public company, regulators have so far let slide for a privately held startup.
None of this changes what Cheung and Shultz did. Whatever legal escape Holmes finds in the years ahead - pardon, early release, or neither - it was two junior lab technicians, willing to risk their careers, who stopped Theranos putting bad results in front of real patients.
Theranos on screen
The Holmes-Theranos story has been well-served by film and TV.
The 2022 TV series "The Dropout" dramatises Holmes' career across eight episodes, from her Stanford ambitions to the moment former Theranos employees broke the story open.
The 2019 documentary "The Inventor: Out for Blood in Silicon Valley" focuses on the gap between Theranos' aggressive marketing and its complete neglect of R&D and medical-authority feedback.
What happened to Erika Cheung?
After leaving Theranos, Cheung spoke about her experience at TEDxBerkeley.
She worked as a research associate at Antibody Solutions, and in 2020 co-founded Ethics in Entrepreneurship, a nonprofit that trains early-stage founders in ethical decision-making - something Cheung describes as having risen "from the ashes of the Theranos scandal." She continues to speak publicly on business ethics, most recently as keynote at the 2024 Olafson Ethics Symposium.
Today Cheung splits time between New York and Los Angeles and still works with Asia-Pacific companies.
Even having lived through the expereince, the documentary was really insightful and offered a fresh perspective on Theranos case. A cautionary tale any entrepreneur can learn from. https://t.co/XnVGLNTmTN
- Erika Cheung (@ErikaMCheung) January 28, 2019
What happened to Tyler Shultz?
After leaving Theranos, Shultz returned to Stanford to work in the Wang Lab on giant magnetoresistive (GMR) sensing. He co-founded Flux Biosciences in 2017 (home diagnostics with a focus on women's fertility) and, in 2022, founded The Healthyr Company, a blood-sample analytics service for early health-issue detection.
He also advises Ethics in Entrepreneurship (Cheung's nonprofit) and The Signals Network, which supports whistleblowers and coordinates international investigative reporting on corporate misconduct and human-rights abuses, and consults for Qvin on menstrual-blood diagnostics.
This has been a long chapter of my life. I am happy that justice has been served and that this saga is finally in my rearview mirror. Proud of the impact that Erika and I had. Hope to inspire other young professionals to hold their leaders accountable.
- tylershultz (@TylerShultz_) January 4, 2022
Being a whistleblower at Theranos came at a personal cost. Shultz's relationship with his grandfather, George Shultz - an early Theranos believer - stayed strained for years.
Did George Shultz apologize to Tyler Shultz?
In a CBS interview on January 4, 2022, Tyler said the two had reconciled before George Shultz died in February 2021. No formal apology ever came, but his grandfather did, eventually, acknowledge that Tyler had been right.
